# Ovarian Cancer Proteogenomics Research Award

Source: https://welltoldgrants.com/grants/w81xwh-22-ocrp-pgra-ovarian-cancer-proteogenomics-research-award/  
Official notice: https://www.grants.gov/search-results-detail/338775

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 2 awards worth $800,000 in total. Applications closed on August 5, 2022.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-22-OCRP-PGRA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | August 5, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 2 |
| Total funding | $800,000 |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The OCRP Proteogenomics Research Award supports the use of proteomics and/or genomics to explore new concepts or theories in ovarian cancer. The award is intended to support the genomic and/or transcriptomic and/or proteomic analysis of currently available clinical specimens with a focus on answering biologic and pathophysiologic questions of clinical relevance in ovarian cancer. The proposed research question should be innovative and have the potential to make an impact on ovarian cancer. Clinical trials are not allowed under the Proteogenomics Research Award mechanism. The analysis of clinical trial-derived specimens and/or large patient specimen cohorts is encouraged. Preliminary data are not required but are allowed. Applicants are encouraged to explore and consider the possible use of the unique proteomics resource at the Women’s Health Integrated Research Center Clinical Proteomics Platform, which was established by the Department of Defense (DOD) intramural Gynecologic Cancer Center of Excellence to provide cutting-edge capabilities for identifying and validating protein biomarkers and surrogates for enhanced cancer patient management through improved early detection, patient stratification, and monitoring for therapeutic efficacy, outcomes, and recurrence.

## Questions people ask

### Is W81XWH-22-OCRP-PGRA still open?

No. It closed on August 5, 2022. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for Ovarian Cancer Proteogenomics Research Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for Ovarian Cancer Proteogenomics Research Award?

Closed August 5, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $800,000 in total across about 2 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.